EICHOR

Recruiting studies: Metastatic Stage Iv Melanoma

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

A Study to Investigate the Efficacy and Safety of an Infusion of IOV-4001 in Adult Participants With Unresectable or Met
Phase 1/Phase 2 · 11 location(s) · Iovance Biotherapeutics, Inc. · NCT05361174 Cryoablation Combined With Stereotactic Body Radiation Therapy for the Treatment of Painful Bone Metastases, the CROME T
NA · 1 location(s) · M.D. Anderson Cancer Center · NCT04693377 Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid
Phase 1 · 3 location(s) · Anusha Kalbasi · NCT04119024 Biomarkers in Immunotherapy of Melanoma
NA · 1 location(s) · Institute of Oncology Ljubljana · NCT05878977 Memory-Like Natural Killer Cells With Nivolumab and Relatlimab in Advanced or Metastatic Melanoma After Progression on C
Phase 1 · 1 location(s) · Washington University School of Medicine · NCT05629546 A Phase 1-1b Study to Evaluate the Safety, Efficacy and Dosimetry of Study Drug A9-3408 in Subjects With Metastatic Mela
Phase 1 · 4 location(s) · Alpha-9 Oncology USA Inc. · NCT07076550 Duration of Anti-PD-1 Therapy in Metastatic Melanoma
Phase 3 · 30 location(s) · Canadian Cancer Trials Group · NCT02821013 IL-17 Blockade to Decrease irAEs (REPLAY)
Phase 1 · 1 location(s) · Duke University · NCT07237594 Follow-up of a National Cohort of Melanoma Resectable Stage II, Stage III or IV Patients or Unresectable Primary
Phase N/A · 27 location(s) · Assistance Publique - Hôpitaux de Paris · NCT02828202 Study to Compare Pharmacokinetics, Efficacy, Safety, and Immunogenicity of MB11 Versus EU-/US-Opdivo® in Subjects With P
Phase 3 · 19 location(s) · mAbxience Research S.L. · NCT07221734 Dietary Fiber to Induce Gut Microbiota-mediated Response to Immunotherapy in Melanoma.
Phase 2 · 2 location(s) · Radboud University Medical Center · NCT07686835 Generation of an Artificial Intelligence Algorithm Based on the Analysis of Melanoma Peri-scar Dermatoheliosis, as a Pre
Phase N/A · 20 location(s) · Nantes University Hospital · NCT05856565 Neoadjuvant Immunotherapy of Operable Metastatic Melanoma in Real Life (GCC)
Phase N/A · 9 location(s) · Centre Hospitalier Universitaire de Besancon · NCT06586593 Tebentafusp and Roginolisib in Uveal Melanoma to Prolong T-cell Homeostasis
Phase 1 · 2 location(s) · St Vincent's Hospital, Sydney · NCT07203391 Physical Activity Directly Before Immunotherapy (Nivolumab and Ipilimumab) in Melanoma
NA · 1 location(s) · Universitätsklinikum Hamburg-Eppendorf · NCT07564570 BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or S
Phase 2 · 225 location(s) · National Cancer Institute (NCI) · NCT05136196 To Evaluate the Safety and Efficacy of ADP-TILIL7 in Patients With Locally Advanced or Metastatic Melanoma
Phase 1 · 2 location(s) · Inge Marie Svane · NCT06204991 A Study Assessing KB707 for the Treatment of Locally Advanced or Metastatic Solid Tumors
Phase 1/Phase 2 · 15 location(s) · Krystal Biotech, Inc. · NCT05970497 Study of CBL0137 in Combination With Ipilimumab and Nivolumab Therapy in Melanoma
EARLY_Phase 1 · 1 location(s) · Fox Chase Cancer Center · NCT05498792 Testing Longer Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With Cancer That Has Spread to
Phase 3 · 270 location(s) · NRG Oncology · NCT06500455 Binimetinib Plus Encorafenib Real Life Investigation of Next Generation Melanoma Treatment
Phase N/A · 59 location(s) · Pierre Fabre Pharma GmbH · NCT04045691 Belvarafenib in Combination With Cobimetinib in Patients With Locally Advanced or Metastatic NRAS-Mutant Melanoma
Phase 2 · 10 location(s) · Hanmi Pharmaceutical Company Limited · NCT07449754 A Study of Radiation Therapy to Treat Solid Tumor Cancer That Has Spread to Soft Tissue
NA · 7 location(s) · Memorial Sloan Kettering Cancer Center · NCT05837767 A Phase Ib Study of PRJ1-3024 for Treatment of Advanced or Metastatic Melanoma
Phase 1/Phase 2 · 1 location(s) · Zhuhai Yufan Biotechnologies Co., Ltd · NCT06727630 Intralesional Influenza Vaccine for the Treatment of Stage I-IV Melanoma
Phase 1 · 1 location(s) · Carlo Contreras · NCT04697576 Cryoablation+Ipilimumab+Nivolumab in Melanoma
Phase 2 · 1 location(s) · Massachusetts General Hospital · NCT05779423 In Vivo Liquid Biopsy of Melanoma (Cytophone)
NA · 1 location(s) · Cytoastra · NCT06488365 Precision Radiation of Immune Checkpoint Therapy Resistant Melanoma Metastases
NA · 1 location(s) · Karolinska University Hospital · NCT04793737 Stereotactic Ablative Radiotherapy (XRT) and Immunotherapy for Oligometastatic Extracranial Melanoma
Phase 2 · 5 location(s) · Melanoma Institute Australia · NCT06767306 A Phase 2 Trial for Metastatic Melanoma Using Adoptive Cell Therapy With Tumor Infiltrating Lymphocytes Plus IL-2 Either
Phase 2 · 1 location(s) · National Cancer Institute (NCI) · NCT02621021

Look up another condition

Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →